Alterations of Genome Network Regulations and Chromatin Configurations related to Carcinogenesis

与癌发生相关的基因组网络调控和染色质构型的改变

基本信息

  • 批准号:
    16590258
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Global gene expression networks in human cells are thought to be regulated by the chromatin configurations. Several histone and DNA modifying enzymes and possibly small noncoding RNAs are major regulators of the chromatin configurations. To clarify the alterations of the chromatin configurations in cancer cells, I studied (1) expressions of histone deacetylase genes, (2) chromatin configurations of TGFβRII promoter, and (3) small noncoding RNAs pathways in lung cancers. Reduced expression of each class II HDAC gene was significantly associated with poor prognosis and an independent predictor of poor prognosis. The group with reduced expression of class II HDACs indicated by the hierarchical clustering analysis showed also poor prognosis. We also studied chromatin configurations of TGFβRII promoter in six lung cancer cell lines. ChIP assays demonstrated three chromatin patterns for this gene silencing (Pattern I : histone H3 acetylation (H3-Ac)(±)/histone H3 lysine 4 methylation (H3K4-Me)(+)/DNA-Me(-), Pattern II; H3-Ac(-)/H3K4-Me(±)/DNA-Me(-), and Pattern III ; H3-Ac(-)/H3K4-Me(-)/DNA-Me(+)). Two members of the double-stranded RNA-specific endonuclease family, Dicer and Drosha, convert precursor forms of microRNA into their mature forms using a stepwise process. We found for the first time that Dicer expression levels were reduced in a fraction of lung cancers with a significant prognostic impact on the survival of surgically treated cases. It should be noted that multivariate COX regression analysis showed that the prognostic impact of Dicer appears to be independent of disease stage.
人类细胞中的全局基因表达网络被认为是由染色质构型调控的。几种组蛋白和DNA修饰酶以及可能的小的非编码RNA是染色质构型的主要调节因子。为了阐明癌细胞染色质构型的改变,我研究了肺癌中的(1)组蛋白去乙酰化酶基因的表达,(2)TGFβRII启动子的染色质构型,和(3)小的非编码RNA通路。每个II类HDAC基因表达的减少与不良预后显著相关,并且是不良预后的独立预测因子。分层聚类分析表明II类HDAC表达降低的组预后也较差。我们还研究了TGFβRII启动子在6个肺癌细胞系中的染色质构型。ChIP试验证明了该基因沉默的三种染色质模式(模式I:组蛋白H3乙酰化(H3-Ac)(±)/组蛋白H3赖氨酸4甲基化(H3 K4-Me)(+)/DNA-Me(-),模式II:H3-Ac(-)/H3 K4-Me(±)/DNA-Me(-),和模式III:H3-Ac(-)/H3 K4-Me(-)/DNA-Me(+))。双链RNA特异性核酸内切酶家族的两个成员Dicer和Drosha使用逐步过程将microRNA的前体形式转化为它们的成熟形式。我们首次发现,Dicer表达水平在一部分肺癌中降低,对手术治疗病例的生存具有显著的预后影响。应该注意的是,多变量考克斯回归分析显示Dicer的预后影响似乎与疾病分期无关。

项目成果

期刊论文数量(77)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers
c-jun 调节的改变及其参与人类肺癌的锚定非依赖性生长
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Maeno;K.;Masuda;A.;Yanagisawa;K.;Konishi;H.;Osada;H.;Saito;T.;Ueda;R.,;Takahashi;T.
  • 通讯作者:
    T.
Histone modification in the TGFβRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
TGFβRII 基因启动子中的组蛋白修饰及其对肺癌细胞系中 HDAC 抑制剂反应的意义。
Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors
  • DOI:
    10.1200/jco.2005.03.8224
  • 发表时间:
    2006-04-10
  • 期刊:
  • 影响因子:
    45.3
  • 作者:
    Takeuchi, T;Tomida, S;Takahashi, T
  • 通讯作者:
    Takahashi, T
Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines
  • DOI:
    10.1158/0008-5472.can-04-0871
  • 发表时间:
    2004-07-15
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    Nakagawa, T;Hayashita, Y;Takahashi, T
  • 通讯作者:
    Takahashi, T
EGFR point mutation in non-small cell lung cancer is occasionally accompanied with second mutation or amplification.
非小细胞肺癌EGFR点突变偶尔伴有二次突变或扩增。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yokoyama T;et. al.
  • 通讯作者:
    et. al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OSADA Hirotaka其他文献

OSADA Hirotaka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OSADA Hirotaka', 18)}}的其他基金

Cell lineage-related mechanisms involved in lung cancer stem cell development.
肺癌干细胞发育中涉及的细胞谱系相关机制。
  • 批准号:
    23501281
  • 财政年份:
    2011
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of epigenetic abnormalities involved in lung cancer progression.
肺癌进展中涉及的表观遗传异常的研究。
  • 批准号:
    20590324
  • 财政年份:
    2008
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of associations between abnormal differentiation and altered regulations of gene expressions.
异常分化与基因表达调节改变之间关联的分子机制。
  • 批准号:
    18590308
  • 财政年份:
    2006
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The mechanism of apoptosis induction by TGF-β stimuli and its clinical application
TGF-β刺激诱导细胞凋亡的机制及其临床应用
  • 批准号:
    13670157
  • 财政年份:
    2001
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvement of LIM domain proteins and Lbd2 in the lung tissue development and carcinogensis.
LIM 结构域蛋白和 Lbd2 参与肺组织发育和致癌作用。
  • 批准号:
    11670158
  • 财政年份:
    1999
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional Characterization of LIMK2 carrying LIM and PDZ Domains in the Developmental and Tumorigenic Process.
携带 LIM 和 PDZ 结构域的 LIMK2 在发育和致瘤过程中的功能表征。
  • 批准号:
    09670170
  • 财政年份:
    1997
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Linking the HTLV-1 pre-integration complex to the chromatin
将 HTLV-1 预整合复合物连接至染色质
  • 批准号:
    MR/Y002083/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Grant
Role of chromatin remodeling in gene regulation during maize basal endosperm development
染色质重塑在玉米基础胚乳发育过程中基因调控中的作用
  • 批准号:
    2341575
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Continuing Grant
How does the chromatin remodeller CHD4 regulate gene expression?
染色质重塑因子 CHD4 如何调节基因表达?
  • 批准号:
    DP240102119
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Discovery Projects
Mechanistic characterisation of enhancer hijacking: identifying essential and targetable chromatin interactions
增强子劫持的机制表征:识别必要的和可靶向的染色质相互作用
  • 批准号:
    MR/Y011902/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Research Grant
Chromatin-binding deubiquitinase MYSM1 as a putative drug target for cMYC-driven B cell lymphoma
染色质结合去泛素酶 MYSM1 作为 cMYC 驱动的 B 细胞淋巴瘤的推定药物靶点
  • 批准号:
    478278
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
Visualising chromatin changes in 3 dimensions: super to ultra resolution
三维可视化染色质变化:超分辨率到超分辨率
  • 批准号:
    DP230103211
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Discovery Projects
ILLUMINATION OF CHROMATIN REGULATION VIA CHEMICAL CONTROLLED PROXIMITY
通过化学控制的接近来阐明染色质调控
  • 批准号:
    10550480
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Structural studies for understanding the mechanism of DNA repair in chromatin
了解染色质 DNA 修复机制的结构研究
  • 批准号:
    23H05475
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Live-Cell Chromatin Imaging and Biology: Application to Extrachromosomal DNA
活细胞染色质成像和生物学:在染色体外 DNA 中的应用
  • 批准号:
    10685017
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples
对福尔马林固定石蜡包埋样品进行可扩展和定量的染色质分析
  • 批准号:
    10696343
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了